Navigation Links
MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen

greements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at www.roche.com <http://www.roche.com/> .

All trademarks used or mentioned in this release are protected by law.

References:

1 Schulz H et al. Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis. Journal of the National Cancer Institute 2007;99(8):706-714

2 Ferlay J, Bray F, Pisani P and Parkin D.M. GLOBOCAN 2002; Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, version 2.0 IARCPress, Lyon, 2004.

Further Information:

- Roche in Oncology: www.roche.com/pages/downloads/company/pdf/mboncology05e_b.pdf <http://www.roche.com/pages/downloads/company/pdf/mboncology05e_b.pdf>

- Lymphoma: www.lymphoma-net.org <http://www.lymphoma-net.org/>

- The Lymphoma Coalition: www.lymphomacoalition.org <http://www.lymphomacoalition.org/>

- Cancer: www.health-kiosk.ch/start_krebs.htm <http://www.health-kiosk.ch/start_krebs.htm>

- World Health Organization:
'"/>




Page: 1 2 3 4

Related medicine technology :

1. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
2. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients

Post Your Comments:
(Date:11/6/2009)... Boston Scientific Corpo...eached an agreement in principle with the U.S. Dep...ries issued by its Guidant subsidiary in 2005. Th... to Boston Scientific,s 2006 acquisition of Guidan...d an investigation by the U.S. Attorney,s Office i...
(Date:11/6/2009)...Newswire-FirstCall/ -- Ardea Biosciences, Inc. (Na...the development of small-molecule therapeutics for...iciency virus (HIV), today reported recent accompl...er and nine months ended September 30, 2009. ,...91104/ARDEALOGO ) ,, "Since our last quarterly ...
(Date:11/6/2009)...wswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulle...Atlanta-based, biopharmaceutical company developin...an Immunodeficiency Virus) and other infectious ag...cial results and provided an operational update. ,...ecutive Officer commented, "We are pleased with ou...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 1Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 2Brain Scans Could Help Spot Schizophrenia Earlier 56674 1Brain Scans Could Help Spot Schizophrenia Earlier 56674 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 1Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 3
... INCLUDE JACKSON BROWNE, MORGAN FREEMAN, SAMUEL L....OODARD, AND FOREST WHITAKER, LOS ANGELES, Oct. 24... South Africa (ANSA) will host "Shaking The Blues,...geles. The evening combines,the power of music and...nal,to the global -- and make a difference in the ...
...hase IIIb clinical study presented at CHEST 2007 o...olution with tiotropium for COPD ...ata presented today at,CHEST 2007, the annual scie...hysicians (ACCP), demonstrate concomitant use of n...ed improved bronchodilation over tiotropium,monoth...
Other Medicine Technology:Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 2Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 2Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 5Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 6
(Date:11/8/2009)...on,s largest network of Hispanic health advocates ...rm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-U...atives showed they have heard the voice of America...for America Act. Now the Senate must deliver, with...e reform," said Dr. Jane L. Delgado, President and...
(Date:11/8/2009)... Praises House Passage of Health Care Reform Bill ...care, improve coverage for all Americans ,, CH...e United States House of Representatives passed by...gislation that would strengthen Medicare for senio...hat prices millions of Americans out of affordable...
(Date:11/7/2009)...NGTON , Nov. 7 Speak...support of H.R. 3962, the Affordable Health Care f...ation later tonight. Below are the Speaker,s rema... is an historic moment for our nation and for Amer...very party and political philosophy -- as far back...
(Date:11/7/2009)...ON, Nov. 7 Members of t...e an emergency resolution rescinding the AMA,s sup...ans that they are responsible to their PATIENTS, n..., Director of Policy for the Association of Americ..., a coalition of other medical groups. ,, "If ...
(Date:11/7/2009)... Nov. 7 Americans United for Life Action endorses...-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith ...ney from going to abortion in health care reform. ...d CEO Dr. Charmaine Yoest said, "Americans United ...orth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendm...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...ssociation Requests AAP Instead Focus on Removing,...ical Treatments for,Children with Autism, CHICAGO...) has initiated a "parent spokesperson" campaign t...ngoing,response to media stories regarding autism ...
...ebruary 11, 2008 -- In forests of the northeastern...nt dissolved forms of sulfur and nitrogen in preci...e in the snowpack and are released to groundwater ...n in poorly buffered soils, ultimately threatening...
... Feb. 15 Canine companions have a paw,up on our f...inarian,leaving cats shortchanged and in need of s...eport appearing in the Feb. 15, 2008, edition,of t... Pet owners, the study found, generally have stro...
...uary 21st at 12:00 p.m. Pacific Time -, MONTVALE,... SYI ) announced today that Noah Berkowitz, M.D.,...nvista will present at,the Roth 20th Annual OC Gro...ifornia. The conference is being held,from Februar...
...ed contraceptive become the first targeted therapy...ation of tamoxifen, from cast-off to lifesaver, la... selective estrogen receptor modulators that coul...e Fox Chase Cancer Center in Philadelphia. , Tod...
...h.---Oxygen, although essential for human life, ca...t toxic to important molecules inside our cells. T...eases, such as Alzheimer,s, heart disease and canc...ademy of Sciences (PNAS), University of Michigan r...
Other Medicine News:Health News:AAP Initiates Public Relations Effort to Counter Bad Vaccine Publicity 2Health News:Melting snow provides clues for acidification 2Health News:Coming to the Defense of Cats 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3Health News:Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators 2
...sional Diagnostics is a leading provider of immuno... test menu that includes kits for autoimmune disea...llaneous conjugates and components. Our Impact IFA...ates and kit sizes to choose from. Kit components ...
...sional Diagnostics is a leading provider of immuno... test menu that includes kits for autoimmune disea...llaneous conjugates and components. Our Impact IFA...ates and kit sizes to choose from. Kit components ...
...s disease ELISA products make us a leader in this ...tegration into the busy laboratory, our Infectious...ity and run-to-run consistency. Our Infectious Dis... for a wide range of serological assays including ...
...s disease ELISA products make us a leader in this ...tegration into the busy laboratory, our Infectious...ity and run-to-run consistency. Our Infectious Dis... for a wide range of serological assays including ...
Medicine Products: